文献速递神经介入CTMRDSA

颅内动脉瘤血管内治疗后对比剂脑病的危险因素与临床策略

Contrast-induced encephalopathy following endovascular treatment for intracranial aneurysms-risk factors analysis and clinical strategy.
PubMed 文献 · Neuroradiology · 2022-10-26

该研究纳入579例接受血管内治疗的未破裂颅内动脉瘤患者,对比剂脑病(CIE)粗发生率为2.4%(95% CI 1.2-3.6%)。主要危险因素包括卒中史(IRR 7.752,P=0.007)、后循环动脉瘤(IRR 9.412,P=0.004)、对比剂剂量较高(IRR 1.018,P=0.007)及高血压史(IRR 1.064,P=0.042)。采取加速对比剂排泄、降低颅内压及抗炎/解痉治疗后,多数患者72小时内完全恢复。

要点

  • 颅内动脉瘤血管内治疗后出现新发神经功能缺损需警惕CIE,CT可见脑水肿和脑沟变浅。
  • 卒中史和后循环动脉瘤是CIE的主要危险因素,对比剂剂量较高和高血压史也需考虑。
  • CIE预后良好,多数患者经加速对比剂排泄、降颅压及抗炎/解痉治疗后72小时内恢复。

核心结论

  • 卒中史和后循环动脉瘤是CIE的主要危险因素,对比剂剂量较高和高血压史也需考虑。
  • 采取加速对比剂排泄、降低颅内压和抗炎/解痉治疗后,多数CIE患者预后良好,72小时内完全恢复。

研究设计与样本

  • 单中心连续队列研究,纳入579例接受血管内治疗的未破裂颅内动脉瘤患者。
  • CIE定义为介入治疗后出现的可逆性神经综合征,伴影像学异常并排除其他疾病。
  • 采用多变量Poisson回归分析,以发生率比(IRR)评估危险因素。

关键影像表现/征象

  • CIE初始症状可表现为头痛、偏瘫和定向障碍,皮质盲是最常见的局灶性缺损。
  • CT上可观察到脑水肿和脑沟变浅,治疗后复查CT/MRI显示无病灶。

诊断标准与关键数值

  • CIE粗发生率为2.4%(95% CI,1.2-3.6%)。
  • 卒中史IRR为7.752(P=0.007),高血压史IRR为1.064(P=0.042)。
  • 后循环动脉瘤IRR为9.412(P=0.004),对比剂剂量较高IRR为1.018(P=0.007)。

临床应用与阅片要点

  • 对具有卒中史、高血压史、后循环动脉瘤或使用较高对比剂剂量的患者,术后新发神经症状应警惕CIE。
  • CT显示脑水肿和脑沟变浅但无明确梗死灶时,需考虑CIE可能,并建议短期复查CT/MRI。
  • 识别CIE后可采用加速对比剂排泄、降低颅内压及抗炎/解痉治疗,预后通常良好。

局限性

  • 单中心研究,结果外推需谨慎。
  • CIE诊断依赖排除其他疾病,可能存在漏诊或误诊。
  • 未报告盲法评估或独立影像判读信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Contrast-induced encephalopathy (CIE) was defined as new onset of neurological deficits after exposure to contrast media, which could be observed after the endovascular treatment for intracranial aneurysms.

METHODS: We enrolled a consecutive cohort of patients who underwent endovascular treatment for unruptured intracranial aneurysms. CIE was defined as a reversible neuropathic syndrome that occurred after interventional therapy, accompanied by imaging abnormalities and excluding other diseases. Multivariable Poisson regression analysis was performed to show risk factors by incidence rate ratio (IRR) and a clinical strategy was proposed.

RESULTS: Among the 579 patients who underwent interventional therapy for intracranial aneurysms, the crude incidence rate of CIE was 2.4% (95% CI, 1.2-3.6%) at our center. Headache, hemiplegia, and disorientation could be initial symptoms, and cortical blindness was the most common localized deficit. Cerebral edema and sulci effacement on CT were observed, and re-revaluation after treatments on CT/MRI showed absent lesions. The risk factors were history of stroke (IRR, 7.752; P = 0.007), history of hypertension (IRR, 1.064; P = 0.042), posterior circulation aneurysms (IRR, 9.412; P = 0.004) and higher dosage of contrast agents (IRR, 1.018; P = 0.007). After the strategy of accelerating excretion of contrast agents, reduction of intracranial pressure and anti-inflammation/vasospasm therapy, the prognosis was favorable with most patients fully recovered within 72 h.

CONCLUSION: History of stroke and posterior circulation aneurysms were main risk factors for CIE. A higher dosage of contrast agents might induce CIE, and the history of hypertension should be considered as well.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Li, Liu, Chen, et al. Contrast-induced encephalopathy following endovascular treatment for intracranial aneurysms-risk factors analysis and clinical strategy. Neuroradiology. 2022. PMID: 36287224. doi:10.1007/s00234-022-03077-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。